Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis Shunsuke Endo, MD, Tsutomu Yamaguchi, MD, Noriko Saito, MD, Shinichi Otani, MD, Tsuyoshi Hasegawa, MD, Yukio Sato, MD, Yasunori Sohara, MD The Annals of Thoracic Surgery Volume 77, Issue 5, Pages 1745-1750 (May 2004) DOI: 10.1016/j.athoracsur.2003.10.039
Fig 1 Number of patients with nonthymomatous myasthenia gravis undergoing transsternal thymectomy with extended anterior mediastinal dissection at Jichi Medical School, 1976–2000. (Programmed Tx = programmed steroid treatment; Occasional Tx = occasional medical treatment.) The Annals of Thoracic Surgery 2004 77, 1745-1750DOI: (10.1016/j.athoracsur.2003.10.039)
Fig 2 Annual changes in the percentage of patients in remission according to severity of myasthenia gravis (MG). (A) Annual changes in the percentage of patients in remission. (B) Annual changes in the percentage of patients with generalized MG in remission. (C) Annual changes in the percentage of patients with ocular MG in remission. (Programmed Tx = programmed steroid treatment; Occasional Tx = occasional medical treatment.) The Annals of Thoracic Surgery 2004 77, 1745-1750DOI: (10.1016/j.athoracsur.2003.10.039)